Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$8M
1 round on record
Latest round
$8M
Series A · Jun 2025 · 15 mo ago
Backers
3
Y Combinator, AgFunder
The money's age
Due for its next round
15 months since the last round · not hiring
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series A | Jun 2025 | $8M | — | webwire.com |
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers

Jiminy's makes dog food and dog treats using nutritious and sustainable insect protein. Great for your dog and the environment. Try…

Revolutionize Your Agriculture Business with Singrow: The Leading Genomic and Precision Agriculture Transformation Platform.

Difficult protein production made simple. A next-generation expression system for next-generation therapeutics.

AffiGEN supplies research-use antibodies, ELISA kits, recombinant proteins, PCR controls, assay kits, cloning reagents and molecular…

The Protein of Choice, manufactured in Australia. Viridian Renewable Technology converts food by-products into premium insect protein…

Braintree Technologies builds autonomous robots and AI-powered software for agriculture. Transforming farming with robotics, geospatial…
News
Resolving In-Vitro Diagnostic Supply Chain Constraints with the EntoEngine
Tech Brief Resolving In-Vitro Diagnostic Supply Chain Constraints with the EntoEngine Learn how the EntoEngine can accelerate commercialization of your assays by securing challenging diagnostic raw material supply. Download the tech brief Back to IVD serv
Read more
Report
Biomanufacturing for Crop Traits Part 1: Understanding Expression Challenges for Plant-Incorporated Protectants (PIPs), Cry, Cyt, and Vip Insecticidal Proteins
Technical Articles 08/24/2026 Biomanufacturing for Crop Traits Part 1: Understanding Expression Challenges for Plant-Incorporated Protectants (PIPs), Cry, Cyt, and Vip Insecticidal Proteins An Overview of Structure, Mechanism of Action, and Recombinant Ex
Read more
Report
Transgenic Fruit Flies vs. Cell Lines: Eliminating Bioreactor Bottlenecks
Technical Articles 07/14/2026 Transgenic Fruit Flies vs. Cell Lines: Eliminating Bioreactor Bottlenecks Learn how the EntoEngine platform bypasses traditional bioreactor bottlenecks using a scale-independent, whole-insect model. Contributors: Ela Dudek Ph
Read more
Report
Overcoming Crop Trait Protein Production Barriers with the EntoEngine
Tech Brief Overcome Crop Trait Protein Production Barriers Learn how the EntoEngine can achieve gram-scale of insect resistance, herbicide tolerance and novel trait protein production for regulatory dossier development Download the tech brief Back to crop
Read more
Report
Transgenic Drosophila Turning Drug Discovery Dead Ends into Runways Future Fields at PEGS 2026
Events 06/04/2026 Transgenic Drosophila Turning Drug Discovery Dead Ends into Runways Future Fields at PEGS 2026 Presentation Recording & Slides Presenter: Matt Anderson-Baron, PhD, co-founder and CEO of Future Fields "What project did you shelve because
Read more
Report
How protein biomanufacturing works in Instar 1.0
Videos 04/30/2026 How protein biomanufacturing works in Instar 1.0 The post How protein biomanufacturing works in Instar 1.0 appeared first on Future Fields.
Read more
Report
Scaling Cell and Gene Therapy Ancillary Materials with the EntoEngine
Scaling Cell and Gene Therapy Ancillary Materials with the EntoEngine Download case study Quality and scale-up bottlenecks still exist for interleukins used as ancillary materials in cell and gene therapy development. This whitepaper highlights how our wh
Read more
Report
From Sequence To Scale In Seven Months: The EntoEngine Achieves Rapid Commercial Scale With Stable Strains
Sequence to Scale in 7 Months: Client Protein Manufacturing Case Study Download case study Future Fields delivered a production campaign with 100% On-Time, In-Full (OTIF) delivery, reflecting exceptional order accuracy and reliability for the mission-crit
Read more
Report
Sequence to Scale in 7 Months Future Fields Presents at PepTalk 2026
Events 02/02/2026 Sequence to Scale in 7 Months Future Fields Presents at PepTalk 2026 Presentation Recording & Slides Presenter: Matt Anderson-Baron, PhD, co-founder and CEO of Future Fields Scaling up in traditional expression systems leads to trade-off
Read more
Report
Manufacturing Glycosylated Erythropoietin Without 𝛼1,3-Fucosylation Using the EntoEngine
The EntoEngine:Insect Glycosylation Case Study Download case study Using Erythropoietin, a critical hormone involved in erythropoiesis, as a model protein, this case study represents a significant step in understanding the glycans presented by Future Fiel
Read more
Report
Show more news
Financials
Total raised
$8M
Latest round
Series A
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Series A | 2025 | $8M | Details |

Y Combinator
AgFunder
Toyota Ventures